Delivery Order SPE2DB22D1202-SPE2DB25FUSX1
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a firm fixed price of $1,342.48 and a period of performance through March 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,061.84, is for the delivery of 4,567,475,840 units of Naloxone HCL 4 mg nasal spray, a critical medication used in the treatment of opioid overdoses. The contract is a firm-fixed-price delivery order with a period of performance through March 6, 2025. This award is part of a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg naloxone hydrochloride nasal spray. The contract has a firm fixed price of $2,281.46 and an ultimate completion date of February 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The delivery order is valued at $2,188.87 and has a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.40, is for the delivery of 4 mg naloxone hydrochloride nasal spray, a critical medication used to treat opioid overdose. The contract has a completion date of February 28, 2025 and was awarded on February 27, 2025 using a firm fixed-price pricing type. This delivery order is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,355.00 fixed-price delivery order is for the supply of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a Delivery Order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of 4 mg nasal spray form of the drug Naloxone Hydrochloride, which is used to treat opioid overdose. The Delivery Order has a ceiling value of $2,292.32 and a completion date of February 14, 2025. The contract is a Firm Fixed Price arrangement. There is no set-aside designation noted for...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Naloxone hydrochloride nasal spray, a medication used to treat opioid overdose. The contract has a Firm Fixed Price pricing type and a ceiling value of $1,193.01. It was awarded on April 17, 2025 with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,630.20 and an ultimate completion date of January 30, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) held by...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FUSX1Delivery Order
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used for the treatment of opioid overdose. The Delivery Order has a Firm Fixed Price of $2,926.80 and a completion date of February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 2/13/25 |